Tikosyn (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Tikosyn drug offered from Avera McKennan Hospital. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | dofetilide |
SUBSTANCE NAME: | DOFETILIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-06-28 |
END MARKETING DATE: | 0000-00-00 |
Tikosyn HUMAN PRESCRIPTION DRUG Details:
Item Description | Tikosyn from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.125(mg/1) |
START MARKETING DATE: | 2016-06-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-5800_e5f28d83-d575-4c10-af66-84c5535f98f7 |
PRODUCT NDC: | 69189-5800 |
APPLICATION NUMBER: | NDA020931 |
Other DOFETILIDE Pharmaceutical Manufacturers / Labelers: